Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 40 | 39 | −1 |
| Shares | 24.1M | 24.0M | −124.9K (−0.5%) |
| Value | $27.0M | $33.6M | +$6.58M (+24.4%) |
New holders (2)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 10,938 | $15.0K | 0.00% |
| ADAR1 Capital Management, LLC | 5,000 | $7.00K | 0.00% |
Sold out (3)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Privium Fund Management (UK) Ltd | 116,516 | $130.5K |
| Jane Street Group, LLC | 56,264 | $63.0K |
| Citigroup Inc | 2,307 | $2.58K |